Search results
Results from the WOW.Com Content Network
Globally, pancreatic cancer is the 11th most-common cancer in women and the 12th most-common in men. [10] The majority of recorded cases occur in developed countries . [ 10 ] People from the United States have an average lifetime risk of about 1 in 67 (or 1.5%) of developing the disease, [ 114 ] slightly higher than the figure for the UK. [ 115 ]
Autoimmune pancreatitis may cause a variety of symptoms and signs, which include pancreatic and biliary (bile duct) manifestations, as well as systemic effects of the disease. Two-thirds of patients present with either painless jaundice due to bile duct obstruction or a "mass" in the head of the pancreas, mimicking carcinoma.
A pancreatic tumor is an abnormal growth in the pancreas. [1] In adults, almost 90% are pancreatic cancer and a few are benign. [1] Pancreatic tumors are rare in children. [1] Classification is based on cellular differentiation (ductal, acinar, neuroendocrine, other) and gross appearance (intraductal, cystic, solid). [1]
Pancreatic cancer, known as the ‘silent killer’, is the third leading cause of cancer-related death in US Maria Menounos reveals symptoms doctors dismissed that turned out to be pancreatic ...
A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of cancers (measure progression or response to therapy). They can be found in bodily fluids or tissue. Markers can help with assessing prognosis, surveilling patients after surgical removal of tumors, and even predicting drug-response and monitor ...
Pancreatic cancer is a type of cancer that starts in the pancreas, an organ that sits behind the stomach and is shaped like a fish with a wide head, a tapering body, and a narrow, pointed tail ...
Papillae vs pseudopapillae: True papillae are outgrowths of epithelium, surrounding fibrovascular cores of stroma and at least one blood vessel. In contrast, pseudopapillae (such as in solid pseudopapillary tumours) are nests of proliferating cells that eventually grow to become almost back-to-back, with cells in the centers of nests disintegrating, leaving rims of cells lining the periphery ...
CA 242 is a tumor marker for sialylated Lewis carbohydrates associated with adenocarcinomas and e-selectin-mediated metastatic risk. [1] [2] [3] It is commonly tested along with CEA, CA19-9, and CA242 for detecting pancreatic cancer. [4] The specificity of CA 242 is higher than similar markers.